AJYG logo

AJ1G, Inc. (AJYG)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

AJ1G, Inc. (AJYG) with AI Score 44/100 (Weak). Global Consortium Inc. (AJYG) operates a cannabis mall in Florida, engaging in cultivation, manufacturing, distribution, and delivery of THC and CBD products. Market cap: 0, Sector: Consumer defensive.

Last analyzed: Mar 17, 2026
Global Consortium Inc. (AJYG) operates a cannabis mall in Florida, engaging in cultivation, manufacturing, distribution, and delivery of THC and CBD products. The company's operations are based in Coconut Creek, Florida.
44/100 AI Score

AJ1G, Inc. (AJYG) Consumer Business Overview

CEOLiangtian Wen
HeadquartersCoconut Creek, US
IPO Year2016

Global Consortium Inc. (AJYG) is a diversified cannabis holding company in Florida, operating a cannabis mall focused on the cultivation, manufacturing, distribution, and delivery of THC and CBD products. It competes in the packaged foods sector with a focus on cannabis-derived edibles and distillates.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 17, 2026

Investment Thesis

Investing in Global Consortium Inc. (AJYG) presents a speculative opportunity within the emerging cannabis market in Florida. With a market capitalization of $0.00B and a high P/E ratio of 14160.05, the company's valuation is sensitive to earnings performance. Key value drivers include the expansion of its cannabis mall operations and the increasing acceptance of cannabis products in Florida. Growth catalysts include potential regulatory changes that could expand the market and increased consumer demand for THC and CBD products. However, the company's high beta of 8.71 indicates significant volatility, and the absence of a dividend may deter income-seeking investors. The company's profitability, indicated by a profit margin of 4.7%, needs to be improved to justify its valuation. Investors should closely monitor regulatory developments, competitive pressures, and the company's ability to scale its operations efficiently.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $0.00B indicates a micro-cap company with high growth potential but also higher risk.
  • P/E ratio of 14160.05 suggests the company is trading at a significant premium relative to its earnings.
  • Profit margin of 4.7% reflects the company's current profitability, which is relatively low and indicates potential for improvement.
  • Beta of 8.71 indicates the stock is significantly more volatile than the market average.
  • The company operates a vertically integrated cannabis mall in Florida, controlling cultivation, manufacturing, distribution, and delivery.

Competitors & Peers

Strengths

  • Vertically integrated operations.
  • Focus on the growing Florida cannabis market.
  • Cannabis mall concept.
  • Offers both THC and CBD products.

Weaknesses

  • Limited geographic presence (Florida only).
  • High P/E ratio indicates overvaluation.
  • Low profit margin.
  • High beta indicates significant volatility.

Catalysts

  • Ongoing: Expansion of cannabis mall operations within Florida.
  • Upcoming: Potential regulatory changes that could expand the cannabis market in Florida.
  • Ongoing: Increased consumer demand for THC and CBD products.
  • Upcoming: Development of new cannabis-infused products.

Risks

  • Ongoing: Changing regulations in the cannabis industry.
  • Ongoing: Intense competition from other cannabis companies.
  • Potential: Potential for federal prohibition of cannabis.
  • Potential: Economic downturn affecting consumer spending.
  • Potential: High volatility due to its OTC status.

Growth Opportunities

  • Expansion of Product Lines: Global Consortium Inc. can expand its product lines to include a wider variety of cannabis-infused products, such as beverages, topicals, and concentrates. The market for cannabis-infused products is growing rapidly, with projections estimating significant growth in the coming years. By diversifying its product offerings, the company can attract a broader customer base and increase its revenue streams. This expansion could be realized within the next 1-2 years, contingent on regulatory approvals and market demand.
  • Geographic Expansion within Florida: While currently focused on Coconut Creek, Global Consortium Inc. can expand its cannabis mall operations to other regions within Florida. The Florida cannabis market is one of the largest in the United States, with significant potential for growth in underserved areas. By establishing new locations, the company can increase its market share and brand recognition. This expansion could be phased over the next 3-5 years, depending on capital availability and regulatory considerations.
  • Strategic Partnerships and Acquisitions: Global Consortium Inc. can pursue strategic partnerships and acquisitions to enhance its capabilities and market reach. Collaborating with other cannabis companies, technology providers, or distribution networks can create synergies and accelerate growth. Acquisitions can provide access to new technologies, products, or markets. These opportunities could materialize within the next 2-3 years, driven by industry consolidation and the need for competitive differentiation.
  • Development of Proprietary Strains: Investing in research and development to create proprietary cannabis strains can provide Global Consortium Inc. with a competitive advantage. Unique strains with specific characteristics, such as higher THC or CBD content, can attract discerning customers and command premium prices. This initiative requires a long-term investment horizon of 3-5 years, but the potential rewards include increased brand loyalty and market differentiation.
  • Enhancement of Delivery Services: Improving and expanding its delivery services can significantly enhance customer convenience and satisfaction. With the increasing popularity of online ordering and home delivery, Global Consortium Inc. can invest in technology and logistics to provide faster and more reliable delivery options. This enhancement can be implemented within the next year, leading to increased customer loyalty and sales.

Opportunities

  • Expansion to other regions in Florida.
  • Development of new cannabis-infused products.
  • Strategic partnerships and acquisitions.
  • Increased legalization and acceptance of cannabis.

Threats

  • Changing regulations in the cannabis industry.
  • Intense competition from other cannabis companies.
  • Potential for federal prohibition of cannabis.
  • Economic downturn affecting consumer spending.

Competitive Advantages

  • Vertically integrated operations provide cost control and supply chain security.
  • Focus on the Florida market provides local expertise and market knowledge.
  • Cannabis mall concept offers a unique retail experience.

About AJYG

Global Consortium Inc., trading under the ticker AJYG, is a cannabis holding company based in Coconut Creek, Florida. The company operates a cannabis mall, integrating cultivation, manufacturing, distribution, and delivery of both THC and CBD distillates and edibles. This vertically integrated approach allows Global Consortium Inc. to control its supply chain from seed to sale, potentially enhancing profitability and ensuring product quality. Founded to capitalize on the burgeoning cannabis market in Florida, the company has positioned itself to serve both recreational and medicinal users. The company's focus on THC and CBD products caters to a wide range of consumer preferences and needs. Global Consortium Inc. aims to establish a strong presence in the Florida cannabis market through strategic cultivation practices, efficient manufacturing processes, and a robust distribution network. The company's operations are entirely based in Florida, making it heavily reliant on the regulatory environment and market dynamics within the state. Its competitive positioning hinges on its ability to offer a diverse product range and maintain operational efficiency within the cannabis industry.

What They Do

  • Operates a cannabis mall in Florida.
  • Cultivates cannabis plants.
  • Manufactures THC and CBD distillates.
  • Produces cannabis-infused edibles.
  • Distributes cannabis products to retail outlets.
  • Provides delivery services for cannabis products.

Business Model

  • Vertically integrated operations from cultivation to retail.
  • Revenue generation through the sale of THC and CBD products.
  • Focus on both recreational and medicinal cannabis markets.

Industry Context

Global Consortium Inc. operates within the rapidly evolving cannabis industry, specifically focusing on the Florida market. The industry is characterized by increasing legalization, growing consumer demand, and intense competition. Market trends include the expansion of both recreational and medicinal cannabis use, as well as the development of innovative products such as edibles and distillates. Competitors include companies like BDPT (Bio-Path Holdings, Inc.), BSFC (Blue Star Foods Corp.), DEWM (Dewmar International BMC, Inc.), DMAN (Demand Brands, Inc.), and KOMOF (Komo Plant Based Foods Inc.), each vying for market share in the cannabis and related sectors. The industry is subject to changing regulations, which can significantly impact market dynamics and company operations. Global Consortium Inc.'s success depends on its ability to navigate these challenges and capitalize on growth opportunities.

Key Customers

  • Recreational cannabis users in Florida.
  • Medicinal cannabis patients in Florida.
  • Retail outlets that sell cannabis products.
AI Confidence: 79% Updated: Mar 17, 2026

Financials

Chart & Info

AJ1G, Inc. (AJYG) stock price: Price data unavailable

Latest News

No recent news available for AJYG.

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AJYG.

Price Targets

Wall Street price target analysis for AJYG.

MoonshotScore

44/100

What does this score mean?

The MoonshotScore rates AJYG's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Liangtian Wen

CEO

Liangtian Wen serves as the Chief Executive Officer of Global Consortium Inc. His background includes experience in business management and strategic development. He has been involved in various entrepreneurial ventures, focusing on emerging markets and innovative business models. Wen's expertise lies in identifying growth opportunities and implementing strategies to capitalize on market trends. His leadership aims to drive Global Consortium Inc.'s expansion and establish a strong presence in the cannabis industry.

Track Record: Under Liangtian Wen's leadership, Global Consortium Inc. has focused on developing its cannabis mall concept and expanding its product offerings. Key milestones include establishing cultivation and manufacturing facilities, securing distribution channels, and launching delivery services. Wen's strategic decisions have aimed to position the company as a vertically integrated player in the Florida cannabis market. The company's focus on both THC and CBD products reflects Wen's vision to cater to a wide range of consumer preferences.

AJYG OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Global Consortium Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and greater price volatility. These companies often have very low trading volume.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: As an OTC stock, AJYG likely suffers from low trading volume and wide bid-ask spreads. This can make it difficult to buy or sell shares at desired prices, especially in large quantities. The limited liquidity can also contribute to increased price volatility. Investors should be prepared for potential challenges in executing trades and should exercise caution when investing in thinly traded OTC stocks like AJYG.
OTC Risk Factors:
  • Limited financial disclosure and transparency.
  • Low trading volume and liquidity.
  • Potential for price manipulation and fraud.
  • Higher risk of delisting or going out of business.
  • Lack of regulatory oversight compared to major exchanges.
Due Diligence Checklist:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's capital structure and debt levels.
  • Check for any legal or regulatory issues.
  • Monitor trading volume and price volatility.
  • Consult with a financial advisor before investing.
Legitimacy Signals:
  • Company has a functioning website and physical address.
  • Management team is identifiable and has relevant experience.
  • Company is registered with the state of Florida.
  • Company has a clear business model and revenue streams.
  • Company complies with state cannabis regulations.

What Investors Ask About AJ1G, Inc. (AJYG)

What does AJ1G, Inc. do?

Global Consortium Inc. (AJYG) operates a cannabis mall in Florida, focusing on the cultivation, manufacturing, distribution, and delivery of THC and CBD distillates and edibles. The company aims to serve both recreational and medicinal cannabis users in the state. Its vertically integrated business model allows it to control the entire supply chain, from seed to sale, potentially enhancing profitability and ensuring product quality. The company's success hinges on its ability to navigate the regulatory landscape and capitalize on the growing demand for cannabis products in Florida.

What do analysts say about AJYG stock?

Currently, there is no available analyst coverage for Global Consortium Inc. (AJYG). The company's micro-cap status and OTC listing may limit institutional interest and analyst attention. Investors should conduct their own due diligence and carefully evaluate the company's fundamentals, growth prospects, and risk factors. The absence of analyst ratings and price targets means that investors must rely on their own research and analysis to make informed investment decisions. The company's high P/E ratio and low profit margin warrant careful scrutiny.

What are the main risks for AJYG?

Investing in Global Consortium Inc. (AJYG) carries several risks, including regulatory uncertainty, intense competition, and potential federal prohibition of cannabis. The company's reliance on the Florida market makes it vulnerable to changes in state regulations. The cannabis industry is highly competitive, with numerous companies vying for market share. The potential for federal prohibition poses a significant threat to the entire industry. Additionally, the company's OTC listing and micro-cap status contribute to increased volatility and liquidity risks. Investors should carefully consider these risks before investing in AJYG.

What is AJYG's strategy for expanding its market share in the competitive cannabis industry?

AJYG intends to expand its market share through a combination of product diversification, geographic expansion within Florida, and strategic partnerships. The company plans to introduce new cannabis-infused products to attract a broader customer base. It also aims to establish new cannabis mall locations in underserved areas of Florida. Furthermore, AJYG is exploring strategic partnerships and acquisitions to enhance its capabilities and market reach. These initiatives are designed to strengthen the company's competitive position and drive revenue growth in the rapidly evolving cannabis market.

How does AJYG ensure the quality and safety of its cannabis products?

AJYG prioritizes the quality and safety of its cannabis products through a vertically integrated operation and adherence to strict quality control measures. The company controls the entire supply chain, from cultivation to retail, allowing it to monitor and manage every step of the process. AJYG implements rigorous testing protocols to ensure that its products meet the highest standards for purity, potency, and safety. The company also complies with all relevant state regulations and licensing requirements to ensure the safety and legality of its operations.

What are the key factors to evaluate for AJYG?

AJ1G, Inc. (AJYG) currently holds an AI score of 44/100, indicating low score. Key strength: Vertically integrated operations.. Primary risk to monitor: Ongoing: Changing regulations in the cannabis industry.. This is not financial advice.

How frequently does AJYG data refresh on this page?

AJYG prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven AJYG's recent stock price performance?

Recent price movement in AJ1G, Inc. (AJYG) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Vertically integrated operations.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Limited information available on OTC-listed companies.
  • Financial data may not be fully reliable due to lack of regulatory oversight.
  • AI analysis pending for AJYG.
Data Sources

Popular Stocks